Value of monitoring urine ammonia at time of biopsy in patients with lupus nephritis.

OBJECTIVE: Although lupus nephritis (LN) is mostly characterized by glomerular involvement, tubular injury is indispensable in its pathogenesis and progression. The purpose of this study is to examine associations between urinary acidification function and clinical and pathological features in LN. METHODS: A total of 103 patients with renal biopsy-proven LN were included, and clinical parameters and laboratory data were obtained from the medical records. Plasma samples, 24-h urine samples and the urinary acidification function, including urine pH, titratable acid, and ammonia, were collected within 3 days before the day of renal biopsy. The correlations between defects of acid excretion and clinical and pathological features were then assessed. Logistic regression analysis was used to assess factors associated with the presence of nephrotic range proteinuria. RESULTS: The urine ammonia level was inversely correlated with SLEDAI-2 K scores, rSLEDAI scores, serum creatinine levels and proteinuria, while it was positively correlated with eGFR. And urine titratable acid was only inversely correlated with rSLEDAI scores and proteinuria. Moreover, urine ammonia had significant negative correlations with AI scores, interstitial inflammatory cell infiltration, CI scores, glomerular sclerosis, fibrous crescents, tubular atrophy and interstitial fibrosis. And urine titratable acid was mainly inversely correlated with CI scores. Furthermore, univariate logistic analyses identified that both urine titratable acid and ammonia were correlated with the presence of nephrotic range proteinuria. After the adjustment for chronicity index and eGFR in a multivariate logistic analysis, only urine titratable acid was still identified as an independent risk factor for the occurrence of nephrotic range proteinuria. CONCLUSIONS: Urine ammonia was associated with clinical and pathological features of chronicity and tubulointerstitial disease activity among patients with lupus nephritis. Furthermore, the strong association between urinary protein and titratable acid excretion at the time of kidney biopsy is significant even after adjusting for the chronicity index and eGFR at biopsy.

Renal tubular acidosis as the initial presentation of Sjögren's syndrome.

We present a 44-year-old female with an initial presentation with distal renal tubular acidosis (RTA) after she presented with hypokalaemia and normal anion gap acidosis. Three years following the diagnosis, she presented with progressive renal impairment. In the absence of any clinical, biochemical and radiological clues, she underwent a renal biopsy which showed severe tubulitis secondary to lymphocytic infiltration. Serological investigations subsequently revealed positive anti-nuclear, anti-Sjögren's syndrome related antigen A (SS-A), and anti-Sjögren's syndrome related antigen B (SS-B) antibodies, supporting the diagnosis of Sjögren's syndrome. This case is unique in that distal RTA was the presenting clinical manifestation of Sjögren's syndrome. We hope that a consideration for Sjögren's syndrome is made in patients with seemingly idiopathic RTA.

Urinary acidification assessed by simultaneous furosemide and fludrocortisone treatment: an alternative to ammonium chloride.

Distal renal tubular acidosis (RTA) can lead to rickets in children or osteomalacia in adults if undetected. This disorder is normally diagnosed by means of an oral ammonium chloride-loading test; however, the procedure often leads to vomiting and abandonment of the test. In this study, we assess an alternative, more palatable approach to test urinary acidification. This was achieved by the simultaneous oral administration of the diuretic furosemide and the mineralocorticoid fludrocortisone to increase distal tubular sodium delivery, principal cell sodium reabsorption, and alpha-intercalated cell proton secretion. We evaluated 11 control subjects and 10 patients with known distal RTA by giving oral ammonium chloride or furosemide/fludrocortisone in random order on separate days. One control and two patients were unable to complete the study owing to vomiting after NH4Cl; however, there were no adverse effects with the furosemide/fludrocortisone treatment. The urine pH decreased to less than 5.3 in the controls with both tests, whereas none of the patients was able to lower the urine pH below 5.3 with either test. We conclude that the simultaneous administration of furosemide and fludrocortisone provides an easy, effective, and well-tolerated alternative to the standard ammonium chloride urinary acidification test for the diagnosis of distal RTA.

Despistaje de acidosis tubular renal distal en preescolares del jardín de infancia Guiri Guire La Guardia, Estado Nueva Esparta: mayo 2005 / Search of acidosis renal distal in preeschool of the childhood garden Guiri Guire La Guardia, Nueva Esparta: may 2005

La acidosis tubular renal distal es un trastorno congénito o adquirido de la acidificación renal consecuencia de disfunción tubular, no presenta manifestaciones clínicas evidentes. Realizar despistaje en preescolares del Jardín de infancia Guiri Guire, La Guardia, Estado Nueva Esparta, en mayo 2005. Estudio Transversal mixto, muestra de 104 preescolares, se tallaron, pesaron, se llenó cuestionario respecto a hábitos alimentarios. Se realizó examen simple de primera orina en ayunas. Aquellos cuyo pH urinario resultó alcalino y/o presentaban cristales de oxalato de calcio pasaron a segunda etapa del estudio que consistió en recolectar muestra de 1ª y 2ª orina en ayunas, 2 muestras de sangre (en ayunas, post prandial) para determinar electrolitos séricos, urinarios, calcio, creatinina séricos, urinarios, y equilibrio ácido base. Los que presentaron acidosis metabólica hiperclorémica con hiato aniónico urinario positivo, se diagnósticaron como acidosis tubular renal distal. La incidencia es de 1,9 por ciento. Se evidenció alta prevalencia de cristales de oxalato de calcio en orina (26,92 por ciento). Del total se encontró un caso con acidosis metabólica hiperclorémica con hiato aniónico urinario negativo. La asociación entre talla baja y acidosis no fue estadísticamente significativa (p=0,906). La asociación entre déficit ponderal y acidosis no fue significativa (p=0,799). La prevalencia de esta patología (2/104) es significativamente mayor que la mundial (1/10000) (Probabilidad de Poisson = 0,00005352). Se recomienda realizar estudios con muestras de mayor tamaño para resultados más precisos del comportamiento de la enfermedad a nivel estatal.

The urine-blood PCO gradient as a diagnostic index of H(+)-ATPase defect distal renal tubular acidosis.

BACKGROUND: Urine pH during acidemia and urine PCO2 upon alkalization both may be useful to indicate H+ secretion from collecting ducts. The urine anion gap has been used to detect urinary NH4+ for differential diagnosis of hyperchloremic metabolic acidosis. We have previously demonstrated that the lack of normal H(+)-ATPase may underlie secretory defect distal renal tubular acidosis (dRTA). In this study we evaluated the diagnostic value of the urine-blood (U-B) PCO2 in H(+)-ATPase defect dRTA, and compared it with that of urine pH and urine anion gap during acidemia. METHODS: In H(+)-ATPase defect dRTA, the diagnostic values of three urinary parameters were evaluated: (1) urine pH measured after acid (NH4Cl) loading; (2) urine-to-blood carbon dioxide tension gradient (U-B PCO2) during alkali (NaHCO3) loading; and (3) urine anion gap during acidemia. Seventeen patients were diagnosed as having H(+)-ATPase defect dRTA based on reduced urinary NH4+ and an absolute decrease in H(+)-ATPase immunostaining in intercalated cells on renal biopsy. Eight patients with non-dRTA renal disease served as control patients. RESULTS: Upon NaHCO3 loading, U-B PCO2 was < or =30 mm Hg in all 17 dRTA patients and >30 mm Hg in all 8 control patients. With NH4Cl loading, urine pH was >5.4 in 15 of 17 dRTA patients and < or =5.4 in 7 of 8 control patients, and the urine anion gap was >5 mmol/L in 13 of 17 dRTA patients and< or =5 mmol/L in 6 of 8 control patients. Therefore, the sensitivity and specificity of U-B PCO2 < or =30 mm Hg during NaHCO3 loading were both 100%, whereas those of urine pH >5.4 or urine anion gap >5 mmol/L during NH4Cl loading were below 90%. In control patients, the U-B PCO2 was found to be well correlated with the urinary NH4+ (r= 0.79, P < 0.05). CONCLUSION: The U-B PCO2 during NaHCO3 loading is an excellent diagnostic index of H(+)-ATPase defect dRTA.

Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing.

The multi-subunit H+-ATPase pump is present at particularly high density on the apical (luminal) surface of -intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification. The complete subunit composition of the apical ATPase, however, has not been fully agreed upon. Functional failure of -intercalated cells results in a group of disorders, the distal renal tubular acidoses (dRTA), whose features include metabolic acidosis accompanied by disturbances of potassium balance, urinary calcium solubility, bone physiology and growth. Mutations in the gene encoding the B-subunit of the apical pump (ATP6B1) cause dRTA accompanied by deafness. We previously localized a gene for dRTA with preserved hearing to 7q33-34 (ref. 4). We report here the identification of this gene, ATP6N1B, which encodes an 840 amino acid novel kidney-specific isoform of ATP6N1A, the 116-kD non-catalytic accessory subunit of the proton pump. Northern-blot analysis demonstrated ATP6N1B expression in kidney but not other main organs. Immunofluorescence studies in human kidney cortex revealed that ATP6N1B localizes almost exclusively to the apical surface of -intercalated cells. We screened nine dRTA kindreds with normal audiometry that linked to the ATP6N1B locus, and identified different homozygous mutations in ATP6N1B in eight. These include nonsense, deletion and splice-site changes, all of which will truncate the protein. Our findings identify a new kidney-specific proton pump 116-kD accessory subunit that is highly expressed in proton-secreting cells in the distal nephron, and illustrate its essential role in normal vectorial acid transport into the urine by the kidney.

[Metabolic acidosis in children: the usefulness of 'anion gap']. / Metabole acidose bij kinderen: het nut van de 'anion gap'.

Metabolic acidosis occurs frequently in small children. The most common causes are hypoxia, sepsis, gastroenteritis and hypovolaemia. Calculation of the anion gap is useful in establishing the cause. An increased anion gap represents unmeasured anions, e.g. lactate in lactic acidosis. Metabolic acidosis was diagnosed in two boys aged one year and six weeks respectively. The first patient had a normal, the second an increased anion gap in blood. By determining the pH and the anion gap in urine it is possible to distinguish between a proximal and a distal tubular disease. The first patient had distal renal tubular acidosis; he recovered after correction of the acidosis. The second patient had a defect in the mitochondrial respiratory chain; he died at the age of seven months.

Distal tubular acidosis induced by FK506.

This study was designed to investigate the effect of tacrolimus (FK506) and of cyclosporine (CsA) on tubular function in renal graft recipients. Patients were randomised after renal transplantation to immunosuppressive treatment with FK506 (n = 8) or CsA (n = 8). Patients had a mean age of 45.7 +/- 3.4 yr; there was no difference in age, sex, HLA status or CMV mismatches. Neither was there any difference in the frequency of episodes of acute kidney failure between the groups, nor was there a significant difference in the frequency of episodes of kidney rejection within the first year. The mean FK506 level at the time lay at 14.7 +/- 14.4 ng/mL whole blood, and the mean CsA level at the time of study was 162 +/- 25 ng/mL whole blood. We performed renal function studies 6 months after transplantation: CIn, CPAH, NaHCO3 loading, and Na2SO4 loading. There was no significant impairment of GFR in patients treated with FK506 with 53.6 +/- 2.5 mL/min as compared to 58 +/- 6 mL in group 2. Plasma renin activity (0.6 +/- 0.4 ng/mL vs 2.3 +/- 3; p < 0.01) and aldosterone (69 +/- 17 vs 157 +/- 28.2 pg/mL; p < 0.05) were significantly decreased during treatment with FK506. Fractional HCO3 excretion was low in both groups, indicating that bicarbonate reabsorption in the proximal nephron was unimpaired. Distal renal tubular acidosis was demonstrated in 4 patients of group 1 but in only 1 of group 2. Potassium levels were slightly increased in patients treated with FK506 (5.4 +/- 0.2 mmoL/L) as compared to cyclosporine (4.9 +/- 0.3 mmoL/L; p < 0.05). Distal hydrogen ion secretion, evaluated by the ability to increase urinary pCO2 in a highly alkaline urine, was impaired in patients treated with FK506 (U-B pCO2: 16.1 +/- 4 vs 36 +/- 5.8; p < 0.05) as compared to patients treated with CsA. The maximum acidification capability (NAE) was slightly lowered during therapy with FK506 (67.5 +/- 11.8 versus 86.6 +/- 16.5 mumoL/min, ns). We conclude that FK506 administration results in a decrease in the rate of hydrogen ion secretion by the collecting tubules. This defect was disclosed by the finding of a subnormal pCO2 in a highly alkaline urine. These results show that FK506 is able to induce distal tubular acidosis. Distal tubular acidosis is part of FK506 induced nephrotoxicity, the pathogenesis of this type of hyperkalemic metabolic acidosis found in patients treated with FK506 after renal transplantation has to be further elucidated.

Acidificación urinaria y artritis reumatoidea / Urinary acidification and rheumatoid arthritis

Con el objetivo de investigar anormalidades subclínicas de la función renal relacionadas con daño tubular (ATRd) en pacientes con Artritis Reumatoidea (AR) se estudiaron en forma prospectiva 25 pacientes: Grupo 1:15 pacientes con AR con una edad promedio de 44 años (28-60) y un tiempo promedio de evolución de 6,5 años (1-22); Grupo 2: 10 pacientes con AR y síndrome de Sjögren (SS) con una edad promedio de 48,5 años (42-54) y un tiempo promedio de evolución de 5,2 años (1-20). Se utilizó como grupo control 20 voluntarios sanos con una edad promedio de 37 años (20-65) sin evidencia de enfermedad renal ni reumática (Grupo 3). Los pacientes de los grupos 1 y 2 no tenían otros antecedentes ni enfermidades que pudieran afectar al parénquima renal ni el medio interno. La función renal era normal. Todos los pacientes recibían antiinflamatorios no esteroides y ninguno sales de oro y/o D-Penicilamina. En todos los casos se realizó un examen clínico, serológico (FR,FAN, Ro, La), estudio oftalmológico, evalución de la secreción salival y en 18/25 biopsia de glándula salival menor. Se valoró la capacidad para acidificar la orina mediante la determinación del gradiente PCO2 urinaria menos la PCO2 venosa (U-B PCO2). Se consideró patológico al gradiente (U-B2 PCO2) menor de 30. Los resultados del gradiente PCO2 U-B (x + 2 ds) fueron: Grupo 1 = 47 + 26 Grupo 2 = 49,8 + 8,4; Grupo 3 = 52,5 + 12,2. No hubo diferencias estadísticamente significativas (F= 1,228727) entre las medias de los tres grupos. De toda la población estudiada sólo un paciente del Grupo 1 (6,6 por ciento) presentó un gradiente PCO2 U-B menor de 30 (el valor fue 5), el tiempo de evolución de su AR era prolongado y se encontraba activa al momento del estudio. En los grupos 2 y 3 no se encontraron alteraciones del gradiente. Concluimos que a pesar de la alta sensibilidad del método utilizado para el diagnóstico precoz del compromiso tubular, nuestra población en estudio no evidenció anormalidades significativas. Además no se encontró correlación entre la serología, el estudio de biopsia de glándula salivar menor y el daño tubular. Tampoco se observó asociación entre la ingesta prolongada de antiinflamatorios no esteroides y la ATRd.

Trastornos de los mecanismos renales de acidificacion en pacientes osteoporóticos / Renal acidification mechanism disorders in patients with osteoporosis

Se apresentaron 8 pacientes (6 mujeres y 2 varones de entre 40 y 67 años) con osteoporosis probablemente secundaria a, o agravada por, defectos tubulares renales. Três de las mujeres eran premenopáusicas; las restantes tenían 9,20 y 22 años de postmenopausia y 2 de ellas recibían terapia de reemplazo hormonal. Dos pacientes tenían nefrolitiasis (un varón con cálculos fosfocálcicos recurrentes y coraliforme izquierdo actual, y una mujer con nefrocalcionosis por riñon en esponja e hipercalciuria). En los restantes enfermos, la sospecha clínica se fundó en: a) Fractura de cadera a los 44 años en mujer premenopáusica sin factores de riesgo aparentes; b) múltiples aplastamientos vertebrales en varón de 45 años sin hipogonadismo ni otros factores presiponentes; c) falta de respuesta favorable a regímines terapéuticos anti-osteoporóticos bien cumplidos en 3 mujeres. Se determinó el nível de bicarbonato sérico en todos los pacientes y se practicó además una prueba de acidificación urinaria aguda con CINH4 o con furosemida oral. Tres pacientes tenían un defecto proximal, cuatro un defecto distal, y uno mixto. Las densidades minerales óseas expresadas en puntaje Z(x ñ e.s) fueron, en columna lumbar, -1,75 ñ 0,08 (n=8), y en cuello femoral -1,57 ñ 0,09 (n=4). Luego de un año de terapia con álcali por vía oral 5 enfermos tuvieron incrementos del calcio esquelético total que oscilaron entre 3 y 10 por ciento. Se concluye que seria conveniente incorporar el bicarbonato sérico a la bateía de pruebas de laboratorio en la evaluación inicial de pacientes osteopénicos, y que deberia sospecharse acidosis tubular renal en pacientes nefrolitiásicos osteopénicos, tengan o no hipercalciuria, y en enfermos osteoporóticos que no respondan a tratamientos probadamente efectivos

Latent distal renal tubular acidosis (dRTA) in primary biliary cirrhosis (PBC) and chronic autoimmune hepatitis (CAH).

In an attempt to evaluate the latent distal renal tubular acidosis (dRTA7) in patients with primary biliary cirrhosis (PBC), and chronic autoimmune hepatitis (CAH), and differences between them in relation to the sodium urinary excretion ([Na]u), thirty four patients divided in two groups were studied. Group A: 17 patients who fulfilled criteria for PBC diagnosis (clinical and humoral evidence antimitochondrial antibody titles of 1/80 or above by indirect immunofluorescence technique, and liver biopsy). Group B: 17 patients who fulfilled criteria for CAH diagnosis (clinical and humoral evidence, antinuclear and smooth muscle antibody titles of 1/80 or above and liver biopsy). Patients with ascitis and/or edema were excluded from the study. Ability to acidify urine was evaluated by gradient between pC02 in urine and blood (U-BpC02) after alkali infusion. Five patients in Group A (29.4%7) and six in Group B(35.2%) had dRTA, (p = 0.49). When analyzing patients with dRTA in both groups, the mean [Na]u in Group A was 152.2 +/- 33.8, versus 50.8 +/- 8.1 mEq/l, in Group B. (p = 0.00016). We concluded that the prevalence of dRTA was similar in patients with PBC and CAH but the urinary acidifications impairment of the former did not correlate with [Na]u, as it did with the latter.

Latent distal renal tubular acidosis (dRTA) in primary biliary cirrhosis (PBC) and chronic autoinmune hepatitis (CAH)

In an attempt to evaluate the latent distal renal tubular acidosis (dRTA7) in patients with primary biliary cirrhosis (PBC), and chronic autoinmmune hepatitis (CAH), and differences between them in relation to the sodium urinary excretion ([a]u), thirty four patients divided in two groups were studied. Group A: 17 patients who fullfilled criteria for PBC diagnosis (clinical and humoral and liver biopsy). Group B: 17 patients who fullfilled criteria for CAH diagnosis (clinical and humoral evidence, antinuclear and smooth muscle antibody tiles of 1/80 or above and liver biopsy). Patients with ascitis and/or edema were excluded form the study. Ability to acidify urine was evaluated by gradient between pCO2 in urine and blood (U-BpC02) after alkali infusion. Five patients with dRTA in both groups, the mean [Na]u in Group A was 152.2 ñ 33.8, versus 50.8 ñ 8.1 mEq/l, in Group B. (p=0.00016). We concluded that the prevalence of dRTA was similar en patiens with PBC and CAH but the urinary acidifications impairment of the former did not correlate with [Na]u, as it did whit the latter

Estudio de la acidificación urinaria mediante la prueba de furosemida / Urinary acidification by furosemide test

Se estudiaron 7 niños sanos de 5 a 9 años de edad, 5 con acidose túbulo renal (ATR) distal no hiperkalémica de 4 a 13 años y 1 con ATR proximal de 20 meses para ver le efecto de la furosemida sobre la acidificación urinaria comparándola con las pruebas de sobrecarga ácida y alcalina. Una hora antes y hasta 4 horas después del suministro de furosemida 2 mg/kg por vía oral se medió pH, pCO2, AT, NH3, creatinina y electrolitos en orina cada 60 minutos y creatinina, pH, PCO2 y electrolitos en sangre al comienzo y al final de la prueba. En los ninos sanos y en el paciente con ATR proximal se comprobó significativa caída del pHu y aumento de la excreción ácida neta. Hubo correlación directa entre pH y flujo urinario. En los niños con ATR distal normokalémica la furosemida no hizo descender el pHu a menos de 6 y la excreción ácida neta permaneció baja. El estímulo sobre la secreción distal de hidrógeno que provocó la furosemida en niños sanos y con ATR proximal podría explicarse por un aumento de la oferta y transporte de sodio en el túbulo colector cortical. En los niños con ATR distal normokalémica, estaría implicada una falla en la secreción ...

Urinary constituents in an endemic area of stones and renal tubular acidosis in northeastern Thailand.

Nephrolithiasis and endemic renal distal tubular acidosis are common in northeastern Thailand. The etiology is still unknown. It is generally accepted that urine electrolytes influence the capacity of urine to inhibit or promote renal and also bladder stones. The purpose of this study was to analyse the composition of the urine in the indigenous population in the northeast area and compare their values with data obtained from a group of age matched adults, living in Bangkok. Twenty-four hour urine samples from 23 normal adult villagers from six villages within the province of Khon Kaen and 34 normal adults living in Bangkok were collected, and the daily excretion of creatinine, uric acid, calcium and inorganic phosphate, sodium, potassium, chloride, magnesium and oxalate were assayed. Daily urinary sodium, potassium, chloride and phosphate of the villagers were significantly lower than those of Bangkokians. No difference in the urinary excretion of calcium, magnesium, uric acid, oxalate and creatinine was found. The Na/Ca, and Ca/PO4 ratios of villagers were significantly lower than those of the Bangkok subjects. The villagers excreted significantly lower amounts of Na in the face of relatively higher urinary Ca. The above data, combined with our previous study showing the low values of urinary citrate in the villagers in the same areas, strongly indicate that the indigeneous population is at high risk in developing urolithiasis. The causes for these electrolyte abnormalities are still unknown. Low contents of the major electrolytes in their diets might play an important role. Low phosphate output indicates low protein diets.(ABSTRACT TRUNCATED AT 250 WORDS)

Renal hypercalciuria and acidification defect in kidney stone patients.

Calcium metabolism and renal acidification ability were examined in renal stone patients. On a random diet 33 of 52 patients excreted more than 4 mg. per kg. body weight per day of urinary calcium and were entered into a second study on a 300 mg. calcium diet. Absorptive and renal hypercalciuria was differentiated by fasting urinary calcium (mg. per 100 ml. glomerular filtration). Every absorptive hypercalciuria patient tested and 5 renal hypercalciuria patients had a normal renal acidification ability, and the serum parathyroid hormone and urinary cyclic adenosine monophosphate levels were normal. By calcium restriction urinary calcium decreased more in absorptive hypercalciuria than in renal hypercalciuria (2.48 +/- 0.14 versus 3.34 +/- 0.27 mg. per kg. body weight per day, p less than 0.05). However, urinary calcium remained high in 76 per cent of the patients with absorptive hypercalciuria. Nine patients had a defect in renal tubular acidification and the calcium metabolism was similar to those with renal hypercalciuria. Present studies show that renal hypercalciuria and renal tubular acidification defect cannot be differentiated without an ammonium chloride test.

Coordinately increased lysozymuria and lysosomal enzymuria induced by maleic acid.

During the acute renal tubular dysfunction of Fanconi syndrome and type 2 renal tubular acidosis (FS/RTA2) induced by maleic acid in the unanesthetized dog, we observed: 30 minutes after the onset of FS/RTA2, the urinary excretion of lysosomal enzymes, N-acetyl-beta-glucosaminidase (NAG), beta-glucuronidase (beta-gluc) and beta-galactosidase (beta-galac), increased simultaneously with the anticipated increase in renal clearance of lysozyme; the severities of all these hyperenzymurias increased rapidly, progressively, and in parallel, all reaching a peak some 60 to 80 minutes after their onset; thereafter, while the FS/RTA2 continued undiminished in severity, the severity of the hyperenzymurias decreased rapidly, greatly, progressively, and in parallel; and sodium phosphate loading strikingly attenuated the FS/RTA2 and the hyperenzymurias. Thus, the maleic acid-induced FS/RTA2 is attended by an acute reversible-complex derangement in the renal tubular processing of proteins that: affects not only lysozyme which is normally filtered, but also NAG and other lysosomal enzymes, which are not; and is to some extent functionally separable from that of FS/RTA2. The findings suggest that the derangements in renal processing of lysozyme and lysosomal enzymes are linked, and that a phosphate-dependent metabolic abnormality in the proximal tubule can participate in the pathogenesis of both these derangements and the FS/RTA2.